Lauris has a strong science background with a degree in Immunology and Biochemistry; and a PhD and 6 years post-doctoral experience covering cell expression systems, protein purification, mass spectrometry, protein crystallography and bioinformatics. Increasingly her portfolio of drafting and prosecution work involves AI. For example, AI cancer diagnostics and AI sequencing analyses. Lauris has also successfully defended key bioinformatics patents for her clients in EPO opposition proceedings.
Lauris is particularly adept with difficult patent cases, both European and US, getting important grants with commercially useful claims for clients. This includes European opposition cases where her attention to detail and tenacity are core to her success.
Having worked with many US in-house counsels including those in the food industry, DNA sequencing technology, microbiome bioinformatics, medical AI applications and antibody therapies to draft applications and manage large European and global portfolios, Lauris knows how to best assist in-house counsel. She adapts her way of working to whatever fits best with the way the in-house team likes to work, effectively becoming another member of the team.
Immunology and Biochemistry
By Managing IP
November 29th 2023
May 10th 2022
March 9th 2021
January 14th 2021
November 17th 2020
The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …Read article
HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …Event details
Porter’s Five Forces model  is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …Read article
In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’ for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …Read article
HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …Event details
“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …Event details
A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted. To many …Read article
Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.